实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (4): 521-524.doi: 10.3969/j.issn.1672-5069.2018.04.009

• 肝癌 • 上一篇    下一篇

根治性切除治疗原发性肝癌患者预后分析*

黄建文, 杨友超, 徐长青, 文天夫   

  1. 620020 四川省眉山市妇幼保健院(黄建文); 四川省丹棱县妇幼保健院(杨友超); 四川省仁寿县人民医院普外科(徐长青); 四川大学华西医院肝胆外科(文天夫)
  • 收稿日期:2017-07-20 出版日期:2018-07-10 发布日期:2018-07-12
  • 作者简介:黄建文,男,49岁,大学本科,副主任医师。E-mail:sgcdij@163.com
  • 基金资助:
    *四川省卫生与健康委员会科研课题(编号:14ZA0192)

Prognosis of patients with primary liver cancer after radical tumor resection

Huang Jianwen, Yang Youchao, Xu Changqing. et al   

  1. Maternal and Child Care Service Hospital,Meishan 620020,Sichuan Province,China
  • Received:2017-07-20 Online:2018-07-10 Published:2018-07-12

摘要: 目的 分析影响原发性肝癌(PLC)患者根治性肿瘤切除术后生存的因素。方法 2008年1月~2012年1月我院行肿瘤根治性手术切除治疗的301例PLC患者,其中肿瘤最大径>5cm组194例,肿瘤直径≤5cm组107例,采用COX回归分析影响患者术后生存的因素。结果 两组术前临床资料比较,除肿瘤直径外,无显著相差(P>0.05);术后1 m,肿瘤直径>5 cm组患者血清甲胎蛋白(AFP)水平显著高于肿瘤直径≤5cm组(P<0.05),而两组肝功能指标比较,无显著性差异(P>0.05);随访发现,肿瘤直径>5cm组患者总生存期为(19.2±3.8)个月,显著短于直径≤5cm组的(29.4±4.2)个月,而直径>5 cm组患者无瘤生存期为(12.3±2.7)个月,也显著短于直径≤5 cm组的(20.9±5.1)个月(P<0.05);经单因素分析显示,年龄>50岁、手术时间超过240 min、术中出血量>500 ml、伴有肝硬化、血清AFP水平高、Child-Pugh 分级低、血清白蛋白水平低、存在血管侵犯和肿瘤直径大的患者总生存时间和无瘤生存时间明显缩短(P<005),进一步经多因素分析显示,肿瘤直径、血管侵犯、Child-Pugh 分级、术中出血量和肝硬化为影响患者总生存期和无瘤生存期的独立危险因素(P均<0.05)。结论 根治性肿瘤切除术为治疗PLC患者的首选方法,但对存在基础肝硬化或Child-Pugh 分级差、肿瘤直径大或有血管侵犯的患者,可能影响术后生存,需要综合考虑治疗方案的制定和选择,以让患者最大获益。

关键词: 原发性肝癌, 根治性肿瘤切除术, 预后, 影响因素

Abstract: Objective To investigate the prognosis of patients with primary liver cancer (PLC) after radical tumor resection and analyze the the factors affecting the survival of patients with PLC after radical tumor resection. Method The clinical and pathological data of 301 patients with PLC(194 with tumor diameter >5 cm and 107 with tumor diameter≤5 cm) were retrospectively analyzed in our hospital between January 2008 and January 2012. All the patients underwent radical tumor resection, and followed-up for four years. The COX regression analysis was applied to determine the factors that might affect the survival of the patients. Result There were no significant differences as respect to the clinical parameters,except the tumor diameters,between the two groups(P>0.05);one month after tumor resection, serum AFP level in patients with tumor diameter >5cm was significantly higher than in those with tumor diameter≤5cm(P<0.05),while the liver function index in the two group were not significantly different (P>0.05);the overall survival (OS) in patients with tumor diameter >5cm was (19.2±3.8) m,much shorter than(29.4±4.2)m in patients with tumor diameter ≤5cm,and the disease-free survival (DFS) in patients with tumor diameter >5cm was(12.3±2.7) m,also significantly shorter than (20.9±5.1) m (P<0.05) in patients with tumor diameter ≤5cm;univariate analysis showed than the OS and DFX in patients older than 50 yr,having operation time longer than 240 min,bleeding greater than 500 ml,with underlying liver cirrhosis,with high serum AFP levels, Child-Pugh class B,low serum albumin levels,vascular invasion and tumor diameters decreased obviously(P<005),and further multivariate analysis demonstrated that tumor diameter,vascular invasion,Child-Pugh class,bleeding and underlying liver cirrhosis were the independent risk factors affecting the patients' OS and DFS (all P<0.05). Conclusion The radical tumor resection might be the first choice in patients with PLC,and the underlying liver cirrhosis and/or the Child-Pugh class,vascular invasion and tumor diameters might affect the post-operational survival,which the surgeons should take into consideration in making choice of interventional approaches in dealing with patients with PLC.

Key words: Hepatoma, Radical tumor resection, Prognosis, Risk factors